Pharma and Biotech Terence Flynn said on a recent episode of Thoughts on the Market. Now, at the same time, employer coverage for obesity treatments is expected to rise from just under 50 percent last year to around 65 percent by 2027. This story doesnt stop at healthcare, Flynn continued
Otake K, Imura T, Sakai H, Abe M
Though committee member Robert Harshbarger, a Tennessee state senator said that emideltide should be available with a valid prescription
The truth lies between hype and fear: semaglutide works through proven mechanisms, but individual safety depends on proper screening, dose management, and medical oversightexactly what PlexusDx delivers through licensed 503A compounding pharmacies across all 50 states
[16] This sensation may range from mild queasiness to more pronounced nausea, particularly after meals
Remote monitoring matches standard IBD follow-up with fewer office visits, trial finds by Doug Brunk In a 24-hospital Spanish randomized trial, patients with active inflammatory bowel disease starting advanced therapy who used a telemonitoring app had disease control noninferior to standard care while making fewer in-person visits
